Advanced Strategies for Poly(3-hydroxybutyrate-co-3-hydroxyvalerate) Production: PHA Synthase Homologous Overexpression in the Extremophile Haloferax mediterranei
Marine Drugs · 11.04.2025 · 23 (4) · 166
DOI: 10.3390/md23040166 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, online erschienen am 11.04.2025. Verfasst von Alexandra Simica und 4 weiteren Autor:innen. Beteiligte Einrichtung: Multidisciplinary Institute for Environmental Studies "Ramón Margalef", University of Alicante, Ap. 99, E-03080 Alicante, Spain. Hauptthemen laut MEDLINE: Haloferax mediterranei, Polyesters, Acyltransferases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Commission, Generalitat Valenciana, Spain, University of Alicante, Spain.
Abstract (Originalsprache)
Bioplastics such as poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) are promising alternatives to conventional plastics. However, the high production cost limits their industrial application. In this study, PHBV production was optimized in Haloferax mediterranei by the homologous overexpression of the key enzyme PHA synthase (PhaEC), resulting in the OEphaEC strain. The growth and PHBV production of OEphaEC compared with the parental strain (HM26) were evaluated in three culture media with different nitrogen sources (KNO3, NH4Cl, and casamino acids). The OEphaEC strain exhibited a 20% increase in PHBV production and a 40% increase in 3-hydroxyvalerate monomer (3HV) content in a defined medium with nitrate as a nitrogen source, as determined by GC-MS. Moreover, enzyme activity, measured spectrophotometrically, increased from 2.3 to 3.9 U/mg. Soluble and insoluble protein fractions were analysed to assess the overexpression of PHA synthase. Only PhaE was found in the insoluble protein fraction, where PHBV granules accumulate. Transmission electron microscopy (TEM) images confirmed a higher PHBV content in OEphaEC compared to the parental strain. These results demonstrate that the homologous overexpression of the key enzyme implicated in PHBV biosynthesis can enhance PHBV content, making its production competitive for industrial applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Multidisciplinary Institute for Environmental Studies "Ramón Margalef", University of Alicante, Ap. 99, E-03080 Alicante, Spain.
- Biotechnology Department, Faculty of Science, University of Alicante Ap. 99, E-03080 Alicante, Spain.
- Biochemistry, Molecular Biology, Edaphology and Agrochemistry Department, Faculty of Science, University of Alicante Ap. 99, E-03080 Alicante, Spain.
ORCID-Profile: Yolanda Segovia, Rosa María Martínez-Espinosa, Carmen Pire
Förderung
- European Commission
- Generalitat Valenciana, Spain
- University of Alicante, Spain
- Universidad de Alicante
Zitieren
APA
Simica, A., Segovia, Y., Navarro-Sempere, A., Martínez-Espinosa, R. M., & Pire, C. (2025). Advanced Strategies for Poly(3-hydroxybutyrate-co-3-hydroxyvalerate) Production: PHA Synthase Homologous Overexpression in the Extremophile Haloferax mediterranei. Marine Drugs, 23(4), 166. https://doi.org/10.3390/md23040166
Vancouver
Simica A, Segovia Y, Navarro-Sempere A, Martínez-Espinosa RM, Pire C. Advanced Strategies for Poly(3-hydroxybutyrate-co-3-hydroxyvalerate) Production: PHA Synthase Homologous Overexpression in the Extremophile Haloferax mediterranei. Marine Drugs. 2025;23(4):166. doi:10.3390/md23040166
BibTeX
@article{Simica2025,
author = {Simica, Alexandra and Segovia, Yolanda and Navarro-Sempere, Alicia and Martínez-Espinosa, Rosa María and Pire, Carmen},
title = {Advanced Strategies for Poly(3-hydroxybutyrate-co-3-hydroxyvalerate) Production: PHA Synthase Homologous Overexpression in the Extremophile Haloferax mediterranei},
journal = {Marine Drugs},
year = {2025},
volume = {23},
number = {4},
pages = {166},
doi = {10.3390/md23040166}
}
EUVIMED